Diverticulitis Disease Market Set to Reach 2.92 Billion by 2029 with 9.4% Yearly Growth

What Is the Estimated Market Size and Growth Rate for the Diverticulitis Disease Market?
The diverticulitis disease market will grow from $1.85 billion in 2024 to $2.04 billion in 2025, at a CAGR of 10.1%. Growth is attributed to the aging population, dietary habits, obesity, and advancements in medical imaging techniques.

The diverticulitis disease market is expected to grow strongly, reaching $2.92 billion by 2029 at a CAGR of 9.4%. Drivers include increased awareness, colonoscopy, and endoscopy advancements. Trends will include preventive care, improved diagnostic tools, and healthcare policy shifts.

What Are the Forces Behind the Rapid Growth of the Diverticulitis Disease Market?
The rising prevalence of smoking addiction is projected to drive the growth of the diverticulitis disease market. Factors such as aggressive marketing, social acceptance, stress, and the addictive properties of nicotine contribute to increasing smoking rates. The availability of e-cigarettes and vape devices, along with social influences, particularly among youth, is also contributing to the growing smoking prevalence. Smoking raises the risk of diverticular disease, which in turn increases the demand for diagnosis and treatment options for diverticulitis. According to Statistics Canada in July 2022, cigarette production rose by 5.8% compared to June 2021, and cigarette sales grew by 1.3%, reaching 1.4 billion in June 2022. Therefore, the increasing rates of smoking addiction are driving the growth of the diverticulitis disease market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12990&type=smp

Who Are the Dominant Companies Influencing Diverticulitis Disease Market Trends?
Major companies operating in the diverticulitis disease market are Pfizer Inc., Johnson and Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma, Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Company, Cipla Limited, Hikma Pharmaceuticals PLC, Endo Pharmaceuticals, Aspen Pharmacare, Zydus Lifesciences, Lupin Limited, Glenmark Pharmaceuticals, Alkem Laboratories, Torrent Pharmaceuticals Ltd.

What Are the Different Segmentations in the Diverticulitis Disease Market?
The diverticulitis disease market covered in this report is segmented -

1) By Type: Uncomplicated, Complicated
2) By Diagnosis: Computed Tomography (CT) Scan, Ultrasound, Urine Test, Blood Test
3) By Treatment: Medications, Surgery, Supportive care, Penicillin Antibiotic, Antibiotics, Dietary Supplements, Intravenous (IV) Fluids
4) By End-User: Specialty Centers, Hospitals, Research centers

Subsegments:
1) By Uncomplicated: Outpatient Treatment, Dietary Management, Antibiotic Therapy
2) By Complicated: Hospitalization, Surgical Intervention, Intravenous Antibiotics, Abscess Drainage

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/diverticulitis-disease-global-market-report

Which Region Is at the Forefront of the Diverticulitis Disease Market?
North America was the largest region in the diverticulitis disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in diverticulitis disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What Is Covered In The Diverticulitis Disease Global Market Report?

- Market Size Analysis: Analyze the Diverticulitis Disease Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Diverticulitis Disease Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Diverticulitis Disease Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Diverticulitis Disease Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12990

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.